GVAX vaccine for pancreatic cancer regulatory update

FDA granted Orphan Drug designation for BioSante's GVAX Pancreas Vaccine to treat pancreatic cancer. The allogeneic cancer vaccine engineered to secrete granulocyte macrophage-colony stimulating facto...